Search in our News Channels PipelineReview.com (press release) The oral presentation titled “Safety and effectiveness of VB-201, a new Immune-modulator, on Inflammation of Atherosclerotic Disease in Patients with Moderate to wicked Plaque Psoriasis : type A Phase 2 Randomized medication Controlled Trial” was specified by Alexa ... Link To Article
No comments:
Post a Comment